[Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI]

Gan To Kagaku Ryoho. 2014 Oct;41(10):1251-3.
[Article in Japanese]

Abstract

A 63-year-old woman with colon cancer who was treated with capecitabine as adjuvant chemotherapy presented with vertigo on day 5, and dysarthria and dysphagia on day 7 of the treatment. Diffusion-weighted magnetic resonance imaging of the brain revealed high signal intensity in the corpus callosum and corona radiata. The patient was diagnosed with acute leukoencephalopathy, and the capecitabine treatment was discontinued. Her symptoms recovered immediately. On the basis of these findings, it can be concluded that diffusion-weighted imaging is useful for the early detection and diagnosis of acute leukoencephalopathy.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Acute Disease
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Capecitabine
  • Colonic Neoplasms / drug therapy*
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Diffusion Magnetic Resonance Imaging
  • Early Diagnosis
  • Female
  • Fluorouracil / adverse effects
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / therapeutic use
  • Humans
  • Leukoencephalopathies / chemically induced*
  • Leukoencephalopathies / pathology
  • Middle Aged

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil